Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42
- PMID: 15659604
- PMCID: PMC6725334
- DOI: 10.1523/JNEUROSCI.4276-04.2005
Copper-dependent inhibition of human cytochrome c oxidase by a dimeric conformer of amyloid-beta1-42
Abstract
In studies of Alzheimer's disease pathogenesis there is an increasing focus on mechanisms of intracellular amyloid-beta (Abeta) generation and toxicity. Here we investigated the inhibitory potential of the 42 amino acid Abeta peptide (Abeta1-42) on activity of electron transport chain enzyme complexes in human mitochondria. We found that synthetic Abeta1-42 specifically inhibited the terminal complex cytochrome c oxidase (COX) in a dose-dependent manner that was dependent on the presence of Cu2+ and specific "aging" of the Abeta1-42 solution. Maximal COX inhibition occurred when using Abeta1-42 solutions aged for 3-6 h at 30 degrees C. The level of Abeta1-42-mediated COX inhibition increased with aging time up to approximately 6 h and then declined progressively with continued aging to 48 h. Photo-induced cross-linking of unmodified proteins followed by SDS-PAGE analysis revealed dimeric Abeta as the only Abeta species to provide significant temporal correlation with the observed COX inhibition. Analysis of brain and liver from an Alzheimer's model mouse (Tg2576) revealed abundant Abeta immunoreactivity within the brain mitochondria fraction. Our data indicate that endogenous Abeta is associated with brain mitochondria and that Abeta1-42, possibly in its dimeric conformation, is a potent inhibitor of COX, but only when in the presence of Cu2+. We conclude that Cu2+-dependent Abeta-mediated inhibition of COX may be an important contributor to the neurodegeneration process in Alzheimer's disease.
Figures
![Figure 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6725334/bin/zns0030599160001.gif)
![Figure 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6725334/bin/zns0030599160002.gif)
![Figure 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6725334/bin/zns0030599160003.gif)
![Figure 4.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6725334/bin/zns0030599160004.gif)
![Figure 5.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/6725334/bin/zns0030599160005.gif)
Similar articles
-
[Brain Function and Pathophysiology Focused on Zn2+ Dynamics].Yakugaku Zasshi. 2022;142(8):855-866. doi: 10.1248/yakushi.22-00074. Yakugaku Zasshi. 2022. PMID: 35908946 Review. Japanese.
-
Copper-dependent inhibition of cytochrome c oxidase by Abeta(1-42) requires reduced methionine at residue 35 of the Abeta peptide.J Neurochem. 2006 Oct;99(1):226-36. doi: 10.1111/j.1471-4159.2006.04050.x. J Neurochem. 2006. PMID: 16987248
-
ApoE and Abeta1-42 interactions: effects of isoform and conformation on structure and function.J Mol Neurosci. 2004;23(3):235-46. doi: 10.1385/JMN:23:3:235. J Mol Neurosci. 2004. PMID: 15181252 Review.
-
Neurotoxic Abeta peptides increase oxidative stress in vivo through NMDA-receptor and nitric-oxide-synthase mechanisms, and inhibit complex IV activity and induce a mitochondrial permeability transition in vitro.J Neurochem. 2001 Feb;76(4):1050-6. doi: 10.1046/j.1471-4159.2001.00112.x. J Neurochem. 2001. PMID: 11181824
-
Substrate-bound beta-amyloid peptides inhibit cell adhesion and neurite outgrowth in primary neuronal cultures.J Neurochem. 2000 Mar;74(3):1122-30. doi: 10.1046/j.1471-4159.2000.741122.x. J Neurochem. 2000. PMID: 10693944
Cited by
-
Neurotoxic β-amyloid oligomers cause mitochondrial dysfunction-the trigger for PANoptosis in neurons.Front Aging Neurosci. 2024 May 14;16:1400544. doi: 10.3389/fnagi.2024.1400544. eCollection 2024. Front Aging Neurosci. 2024. PMID: 38808033 Free PMC article. Review.
-
Mitochondrial Complex I and β-Amyloid Peptide Interplay in Alzheimer's Disease: A Critical Review of New and Old Little Regarded Findings.Int J Mol Sci. 2023 Nov 3;24(21):15951. doi: 10.3390/ijms242115951. Int J Mol Sci. 2023. PMID: 37958934 Free PMC article. Review.
-
Photo-Induced Cross-Linking of Unmodified α-Synuclein Oligomers.ACS Chem Neurosci. 2023 Sep 6;14(17):3192-3205. doi: 10.1021/acschemneuro.3c00326. Epub 2023 Aug 24. ACS Chem Neurosci. 2023. PMID: 37621159 Free PMC article.
-
Systematic review of 31P-magnetic resonance spectroscopy studies of brain high energy phosphates and membrane phospholipids in aging and Alzheimer's disease.Front Aging Neurosci. 2023 May 18;15:1183228. doi: 10.3389/fnagi.2023.1183228. eCollection 2023. Front Aging Neurosci. 2023. PMID: 37273652 Free PMC article.
-
Interactions between amyloid, amyloid precursor protein, and mitochondria.Biochem Soc Trans. 2023 Feb 27;51(1):173-182. doi: 10.1042/BST20220518. Biochem Soc Trans. 2023. PMID: 36688439 Free PMC article.
References
-
- Anderson MF, Sims NR (2000) Improved recovery of highly enriched mitochondrial fractions from small brain tissue samples. Brain Res Protoc 5: 95-101. - PubMed
-
- Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NME, Romano DM, Hartshorn MA, Tanzi RE, Bush AI (1998) Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 273: 12817-12826. - PubMed
-
- Atwood CS, Perry G, Zeng H, Kato Y, Jones WD, Ling K-Q, Huang X, Moir RD, Wang D, Sayre LM, Smith MA, Chen SG, Bush AI (2004) Copper mediates dityrosine cross-linking of Alzheimer's amyloid-β. Biochemistry 43: 560-568. - PubMed
-
- Bitan G, Lomakin A, Teplow DB (2001) Amyloid β-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem 276: 35176-35184. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources